• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
GUO Wei, WANG Chen, WANG Yuheng, GAO Xiangdong. Expression, purification and functional assay of rhIL23R-CHR[J]. Journal of China Pharmaceutical University, 2013, 44(6): 583-588. DOI: 10.11665/j.issn.1000-5048.20130619
Citation: GUO Wei, WANG Chen, WANG Yuheng, GAO Xiangdong. Expression, purification and functional assay of rhIL23R-CHR[J]. Journal of China Pharmaceutical University, 2013, 44(6): 583-588. DOI: 10.11665/j.issn.1000-5048.20130619

Expression, purification and functional assay of rhIL23R-CHR

More Information
  • The IL23R-CHR gene was cloned from human leukocyte cDNA library and inserted into pMD18T vector. The recombinant plasmid was confirmed by DNA sequencing. Followed, the IL23R-CHR was subcloned into pET22b/pET28a/pET32a vector, and then the recombinant expression plasmids were transformed into BL21(DE3). In this study, we optimized the expression condition by comparing direct expression between soluble fusion protein expression, secretion expression and inclusion body expression. Finally, hIL23R-CHR was expressed and purified from Trx-hIL23R-CHR fusion protein with a purity of 90%. Affinity assay also demonstrated that purified hIL23R-CHR was able to bind to human IL-23. Histological examination revealed that hIL23R-CHR can protect the central nervous system of EAE mice.
  • [1]
    Zhou L,Ivanov II,Spolski R,et al.IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways[J].Nat Immunol,2007,8(9):967-74.
    [2]
    Chen Y, Claire LL, Brent M, et al. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis[J].J Clin Invest,2006,116(5):1 317-1 326.
    [3]
    Miossec P,Kolls JK.Targeting IL-17 and TH17 cells in chronic inflammation[J].Nat Rev Drug Discov,2012,11(10):763-776.
    [4]
    Bettelli E,Korn T,Oukka M,et al.Induction and effector functions of T(H)17 cells[J].Nature,2008,453(7 198):1 051-1 057.
    [5]
    Ciofani M,Madar A,Galan C,et al.A validated regulatory network for Th17 cell specification[J].Cell,2012,151(2):289-303.
    [6]
    Griffiths CE,Strober BE,van de Kerkhof P,et al.Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis[J].N Engl J Med,2010,362(2):118-128.
    [7]
    Sandborn WJ,Gasink C,Gao LL,et al.Ustekinumab induction and maintenance therapy in refractory Crohn′s disease[J].N Engl J Med,2012,367(16):1 519-1 528.

Catalog

    Article views (1192) PDF downloads (1880) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return